Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Go back to Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer| AGENUS (NASDAQ: AGEN) | Delayed: 7.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.53 | 52 Week High | $7.49 | |||
| Open | $7.53 | 52 Week Low | $2.61 | |||
| Day High | $7.53 | P/E | N/A | |||
| Day Low | $7.53 | EPS | $-1.10 | |||
| Volume | 1,708 | |||||
| (NASDAQ: GANX) | Delayed: 2.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.03 | 52 Week High | $ | |||
| Open | $2.03 | 52 Week Low | $ | |||
| Day High | $2.03 | P/E | N/A | |||
| Day Low | $2.03 | EPS | $ | |||
| Volume | 5 | |||||
